Amgen Inc (AMGN)

220.82 -0.04  -0.02% NASDAQ Nov 18, 16:59 Delayed 2m USD

Amgen Cash from Operations (TTM):

9.83B for Sept. 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Operations (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Operations (TTM) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2019 9.83B
June 30, 2019 9.726B
March 31, 2019 10.41B
Dec. 31, 2018 11.30B
Sept. 30, 2018 11.11B
June 30, 2018 11.30B
March 31, 2018 11.52B
Dec. 31, 2017 11.18B
Sept. 30, 2017 11.26B
June 30, 2017 10.47B
March 31, 2017 10.82B
Dec. 31, 2016 10.35B
Sept. 30, 2016 9.327B
June 30, 2016 9.557B
March 31, 2016 10.16B
Dec. 31, 2015 9.731B
Sept. 30, 2015 10.50B
June 30, 2015 10.35B
March 31, 2015 9.292B
Dec. 31, 2014 8.952B
Sept. 30, 2014 7.945B
June 30, 2014 7.011B
March 31, 2014 6.384B
Dec. 31, 2013 6.291B
Sept. 30, 2013 5.268B
   
June 30, 2013 5.184B
March 31, 2013 5.959B
Dec. 31, 2012 5.882B
Sept. 30, 2012 6.654B
June 30, 2012 5.90B
March 31, 2012 5.061B
Dec. 31, 2011 5.119B
Sept. 30, 2011 5.543B
June 30, 2011 5.876B
March 31, 2011 5.904B
Dec. 31, 2010 5.787B
Sept. 30, 2010 5.602B
June 30, 2010 6.275B
March 31, 2010 6.39B
Dec. 31, 2009 6.336B
Sept. 30, 2009 5.91B
June 30, 2009 5.325B
March 31, 2009 5.265B
Dec. 31, 2008 5.988B
Sept. 30, 2008 6.121B
June 30, 2008 6.319B
March 31, 2008 6.09B
Dec. 31, 2007 5.401B
Sept. 30, 2007 5.113B
June 30, 2007 5.098B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Operations

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.

Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More

Advertisement

Cash from Operations (TTM) Benchmarks

Benchmarks
Abbott Laboratories 5.485B
Biogen Inc 7.014B
Celgene Corp 8.158B

Cash from Operations (TTM) Range, Past 5 Years

Minimum 8.952B Dec 2014
Maximum 11.52B Mar 2018
Average 10.36B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.